Paragon 28 Inc
NYSE:FNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Paragon 28 Inc
NYSE:FNA
|
US |
|
K
|
Kioxia Holdings Corp
TSE:285A
|
JP |
|
Guangdong Sanhe Pile Co Ltd
SZSE:003037
|
CN |
|
F
|
Financiera Independencia SAB de CV SOFOM ENR
BMV:FINDEP
|
MX |
|
Y
|
Ybox Real Estate Ltd
TASE:YBOX
|
IL |
|
Novatek Microelectronics Corp
TWSE:3034
|
TW |
|
I
|
iStar Inc
F:OLZ
|
US |
|
H
|
Hilan Ltd
TASE:HLAN
|
IL |
|
Logistec Corp
TSX:LGT.B
|
CA |
|
D
|
DA Technology Co Ltd
KOSDAQ:196490
|
KR |
Paragon 28 Inc
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
